Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

• Main Authors: Bin Su (Author), Yin Wang (Author), Ruifeng Zhou (Author), Taiyi Jiang (Author), Hongwei Zhang (Author), Zaicun Li (Author), An Liu (Author), Ying Shao (Author), Wei Hua (Author), Tong Zhang (Author), Hao Wu (Author), Shenghua He (Author), Lili Dai (Author), Lijun Sun (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Lopinavir/ritonavir (LPV/r) is a major antiretroviral treatment in China, but little is known about the performance of first-line LPV/r-based regimen in treatment-naïve patients with human immunodeficiency virus type 1 (HIV-1) infection. This study aims to assess the efficacy and adverse...